Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes: Gusto IV-ACS

This publication has 8 references indexed in Scilit:

• ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
  Circulation, 2000
• Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology Recommendations of the Task Force of the European Society of Cardiology
  European Heart Journal, 2000
• The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
  JAMA, 2000
• Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial
  European Heart Journal, 1999
• Angiographic Findings in Patients With Refractory Unstable Angina According to Troponin T Status
  Circulation, 1999
• Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention
  The American Journal of Cardiology, 1999
• Platelet Glycoprotein IIb/IIIa Antagonists
  Circulation, 1999
• Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
  Circulation, 1994